|
1
Порядок, установленный Национальной службой здравоохранения Великобритании (NHS), предполагает, что с любой проблемой женщина сначала обращается к врачу общей практики. Если проблема серьезная и врач общей практики не видит возможности поставить диагноз и назначить лечение, он направляет пациентку на анализы (общий анализ крови, мочи и проч.) и на прием к узкому специалисту. Такая система позволяет разгрузить узких специалистов, пациентка приходит к ним уже с результатами анализов, и они могут быстрее оказать ей помощь. Самостоятельно записаться к узкому специалисту, минуя врача общей практики, можно только в частных клиниках. В дальнейшем упоминания о том, что начинать поиск решения проблемы нужно с визита к врачу общей практики, встретятся во всех главах этой книги. – Прим. перев.
2
Слова «вагина» и «влагалище» – синонимы, поэтому в переводе они употребляются как взаимозаменяемые. – Прим. перев.
3
1. Lloyd J., Crouch N. S., Minto C. L., Liao L. M., Creighton S. M. Female genital appearance: “normality” unfolds. BJOG 2005; 112(5): 643–6.
4
2. Rowen T. S., Gaither T. W., Awad M. A., Osterberg E. C., Shindel A. W., Breyer B. N. Pubic Hair Grooming Prevalence and Motivation Among Women in the United States. JAMA Dermatol 2016; 152(10): 1106–13.
5
3. Schreiner L., Crivelatti I., de Oliveira J. M., Nygaard C. C., Dos Santos T. G. Systematic review of pelvic floor interventions during pregnancy. Int J. Gynaecol Obstet 2018.
6
4. Woodley S. J., Boyle R., Cody J. D., Morkved S., Hay-Smith E.J.C. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2017; 12: CD007471.
7
5. Younis M. T., Iram S., Anwar B., Ewies A. A. Women with asymptomatic cervical polyps may not need to see a gynaecologist or have them removed: an observational retrospective study of 1126 cases. Eur J. Obstet Gynecol Reprod Biol 2010; 150(2): 190–4.
8
6. Tarney C. M., Han J. Postcoital bleeding: a review on etiology, diagnosis, and management. Obstet Gynecol Int 2014; 2014: 192087.
9
7. Royal College of Obstetricians & Gynaecologists. Ovarian Masses in Premenopausal Women, Management of Suspected (Green-top Guideline No. 62). 2011.
10
8. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011; 105 Suppl 2: S77–81.
11
1. Johnson S, Marriott L, Zinaman M. Can apps and calendar methods predict ovulation with accuracy? Curr Med Res Opin 2018: 1–18.
12
2. Dasharathy SS, Mumford SL, Pollack AZ, et al. Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol 2012; 175(6): 536–45.
13
3. Cole LA, Ladner DG, Byrn FW. The normal variabilities of the menstrual cycle. Fertil Steril 2009; 91(2): 522–7.
14
4. Howard C, Rose CL, Trouton K, et al. FLOW (finding lasting options for women): multicentre randomized controlled trial comparing tampons with menstrual cups. Can Fam Physician 2011; 57(6): e208–15.
15
5. Meaddough EL, Olive DL, Gallup P, Perlin M, Kliman HJ. Sexual activity, orgasm and tampon use are associated with a decreased risk for endometriosis. Gynecol Obstet Invest 2002; 53(3): 163–9.
16
Автор – британка, и адресована ее книга прежде всего британкам, поэтому многие реалии и отсылки в тексте относятся исключительно к Великобритании и населению этой страны (например, особенности системы здравоохранения или законодательство об абортах). В России и других странах ситуация, конечно, другая, и это следует учитывать. – Прим. перев.
17
6. Mitchell MA, Bisch S, Arntfield S, Hosseini-Moghaddam SM. A confirmed case of toxic shock syndrome associated with the use of a menstrual cup. Can J Infect Dis Med Microbiol 2015; 26(4): 218–20.
18
7. Archer JC, Mabry-Smith R, Shojaee S, Threet J., Eckert JJ, Litman VE. Dioxin and furan levels found in tampons. J Womens Health (Larchmt) 2005; 14(4): 311–5.
19
8. DeVito MJ, Schecter A. Exposure assessment to dioxins from the use of tampons and diapers. Environ Health Perspect 2002; 110(1): 23–8.
20
9. Strotmeyer ES, Steenkiste AR, Foley TP, Jr., Berga SL, Dorman JS. Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 2003; 26(4): 1016–21.
21
10. Solomon CG, Hu FB, Dunaif A, et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001; 286(19): 2421–6.
22
11. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41.
23
12. Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab (Lond) 2005; 2: 35.
24
13. Lee I, Cooney LG, Saini S, et al. Increased risk of disordered eating in polycystic ovary syndrome. Fertil Steril 2017; 107(3): 796–802.
25
14. Eslamian G, Baghestani AR, Eghtesad S, Hekmatdoost A. Dietary carbohydrate composition is associated with polycystic ovary syndrome: a case-control study. J Hum Nutr Diet 2017; 30(1): 90–7.
26
15. Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and metaanalysis. Hum Reprod 2017; 32(5): 1075–91.
27
16. Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update 2016; 22(3).
28
17. Pundir J, Psaroudakis D, Savnur P, et al. Inositol treatment of anovulation in women with polycystic ovary syndrome: a metaanalysis of randomised trials. BJOG 2018; 125(3): 299–308.
29
18. Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA. Incidence of ovulation in the years after the menarche. J Endocrinol 1983; 97(2): 213–9.
30
19. Harris HR, Titus LJ, Cramer DW, Terry KL. Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer 2017; 140(2): 285–91.
31
20. Harris HR, Terry KL. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract 2016; 2: 14.
32
21. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 2007; 16(2): 276–80.
33
22. Voskuil DW, Monninkhof EM, Elias SG, et al. Physical activity and endometrial cancer risk, a systematic review of current evidence. Cancer Epidemiol Biomarkers Prev 2007; 16(4): 639–48.
34
23. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries – a common finding in normal women. Lancet 1988; 1(8590): 870–2.
35
24. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol 2001; 98(5 Pt 1): 806–14.
36
25. Duckitt K, Collins S. Menorrhagia. BMJ Clin Evid 2008; 2008.
37
25. Duckitt K, Collins S. Menorrhagia. BMJ Clin Evid 2008; 2008.
38
26. Zahradnik HP, Hanjalic-Beck A, Groth K. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review. Contraception 2010; 81(3): 185–96.
39
27. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2015; (7): CD001751.
40
28. Dehnavi ZM, Jafarnejad F, Kamali Z. The Effect of aerobic exercise on primary dysmenorrhea: A clinical trial study. J Educ Health Promot 2018; 7: 3.
41
29. Kikuchi H, Nakatani Y, Seki Y, et al. Decreased blood serotonin in the premenstrual phase enhances negative mood in healthy women. J Psychosom Obstet Gynaecol 2010; 31(2): 83–9.
42
30. Lanza di Scalea T, Pearlstein T. Premenstrual Dysphoric Disorder. Psychiatr Clin North Am 2017; 40(2): 201–16.
43
30. Lanza di Scalea T, Pearlstein T. Premenstrual Dysphoric Disorder. Psychiatr Clin North Am 2017; 40(2): 201–16.
44
31. Pennant ME, Mehta R, Moody P, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG 2017; 124(3): 404–11.
45
31. Pennant ME, Mehta R, Moody P, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG 2017; 124(3): 404–11.
46
32. Pattanittum P, Kunyanone N, Brown J, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev 2016; 3: CD002124.
47
Скрининг – это обследование всех женщин, входящих в группу риска развития рака шейки матки. У большинства из них симптомов нет. Скрининг позволяет выявить предраковые изменения, которые при отсутствии лечения могут привести к развитию рака. – Прим. перев.
48
1. McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992; 1(2): 125–9.
49
2. Windham GC, Mitchell P, Anderson M, Lasley BL. Cigarette smoking and effects on hormone function in premenopausal women. Environ Health Perspect 2005; 113(10): 1285–90.
50
3. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997; 315(7112): 841–6.
51
4. Brotman RM, He X, Gajer P, et al. Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect Dis2014; 14: 471.
52
6. Bisschop MP, Merkus JM, Scheygrond H, van Cutsem J. Co-treatment of the male partner in vaginal candidosis: a doubleblind randomized control study. Br J Obstet Gynaecol 1986; 93(1): 79–81.
53
7. Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 2013; 17(3): 340–5.
54
8. Xie HY, Feng D, Wei DM, et al. Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database Syst Rev 2017; 11: CD010496.
55
9. Brotman RM, Shardell MD, Gajer P, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 2014; 21(5): 450–8.
56
4. Brotman RM, He X, Gajer P, et al. Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect Dis2014; 14: 471.
57
10. Larsson PG. Treatment of bacterial vaginosis. Int J STD AIDS 1992; 3(4): 239–47.
58
11. Homayouni A, Bastani P, Ziyadi S, et al. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J Low Genit Tract Dis 2014; 18(1): 79–86.
59
12. Amaya-Guio J, Viveros-Carreno DA, Sierra-Barrios EM, Martinez-Velasquez MY, Grillo-Ardila CF. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database Syst Rev 2016; 10: CD011701.
60
13. Ogbolu DO, Oni AA, Daini OA, Oloko AP. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria. J Med Food 2007; 10(2): 384–7.
61
14. te Velde ER, Eijkemans R, Habbema HD. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet 2000; 355(9219): 1928–9.
62
15. World Health Organization. WHO Model Lists of Essential Medicines. 2017. http://www.who.int/medicines/publications/essentialmedicines/en/.
63
16. Cea-Soriano L, Garcia Rodriguez LA, Machlitt A, Wallander MA. Use of prescription contraceptive methods in the UK general population: a primary care study. BJOG 2014; 121(1): 53–60; discussion-1.
64
17. Superdrug/United Nations. Birth Control Around The World. 2017. https://onlinedoctor.superdrug.com/birth-control-around-the-world/.
65
18. Killick SR, Leary C, Trussell J, Guthrie KA. Sperm content of preejaculatory fluid. Hum Fertil (Camb) 2011; 14(1): 48–52.
66
19. National Health Service. Sexual and Reproductive Health Services – England 2016–17. https://digital.nhs.uk/catalogue/PUB30094.
67
20. Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am J Obstet Gynecol 2017; 216(6): 580 e1– e9.
68
21. Office For National Statistics. Cancer registration statistics, England. 2016. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/ conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2016.
69
22. Cancer Research UK. Cancer mortality statistics. 2017. http://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality/common-cancers-compared.
70
20. Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am J Obstet Gynecol 2017; 216(6): 580 e1– e9.
71
20. Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am J Obstet Gynecol 2017; 216(6): 580 e1– e9.
72
23. Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014; (1): CD003987.
73
24. Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012; 345: e4944.
74
25. Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016; (8): CD008815.
75
26. NICE. Clinical Knowledge Summary: Contraception – progestogen-only methods. 2017. https://cks.nice.org.uk/contraception-progestogen-only-methods.
76
27. Tyler KH, Zirwas MJ. Contraception and the dermatologist. J Am Acad Dermatol 2013; 68(6): 1022–9.
77
25. Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016; (8): CD008815.
78
28. Lopez LM, Chen M, Mullins Long S, Curtis KM, Helmerhorst FM. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 2015; (7): CD009849.
79
29. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002; 65(2): 129–32.
80
30. Lethaby A, Hussain M, Rishworth JR, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2015; (4): CD002126.
81
31. Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use. Contraception 2018; 97(3): 210–4.
82
32. Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012; 97(3): 616–22 e1-3.
83
33. Crosby RA, DiClemente RJ, Wingood GM, Lang D, Harrington KF. Value of consistent condom use: a study of sexually transmitted disease prevention among African American adolescent females. Am J Public Health 2003; 93(6): 901–2.
84
34. Andrade AT, Pizarro Orchard E. Quantitative studies on menstrual blood loss in IUD users. Contraception 1987; 36(1): 129–44.
85
35. Hubacher D, Chen PL, Park S. Side effects from the copper IUD: do they decrease over time? Contraception 2009; 79(5): 356–62.
86
36. Duane M, Contreras A, Jensen ET, White A. The Performance of Fertility Awareness-based Method Apps Marketed to Avoid Pregnancy. J Am Board Fam Med 2016; 29(4): 508–11.
87
37. Berglund Scherwitzl E, Gemzell Danielsson K, Sellberg JA, Scherwitzl R. Fertility awareness-based mobile application for contraception. Eur J Contracept Reprod Health Care 2016; 21(3): 234–41.
88
19. National Health Service. Sexual and Reproductive Health Services – England 2016–17. https://digital.nhs.uk/catalogue/PUB30094.
89
38. Belker AM, Thomas AJ, Jr., Fuchs EF, Konnak JW, Sharlip ID. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol 1991; 145(3): 505–11.
90
39. Barnhart KT, Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertil Steril 2009; 91(3): 659–63.
91
40. Glasier A. Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 2002; 65(1): 29–37.
92
41. Stoddard AM, Xu H, Madden T, Allsworth JE, Peipert JF. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care 2015; 20(3): 223–30.
93
42. Jain J, Dutton C, Nicosia A, Wajszczuk C, Bode FR, Mishell DR, Jr. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception 2004; 70(1): 11–8.
94
43. Skovlund CW, Morch LS, Kessing LV, Lidegaard O. Association of Hormonal Contraception With Depression. JAMA Psychiatry 2016; 73(11): 1154–62.
95
44. Wirehn AB, Foldemo A, Josefsson A, Lindberg M. Use of hormonal contraceptives in relation to antidepressant therapy: A nationwide population-based study. Eur J Contracept Reprod Health Care 2010; 15(1): 41–7.
96
45. Schaffir J, Worly BL, Gur TL. Combined hormonal contraception and its effects on mood: a critical review. Eur J Contracept Reprod Health Care 2016; 21(5): 347–55.
97
46. Worly BL, Gur TL, Schaffir J. The relationship between progestin hormonal contraception and depression: a systematic review. Contraception 2018.
98
47. Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception 2007; 75(1): 27–31.
99
48. Fergusson DM, Horwood LJ, Boden JM. Abortion and mental health disorders: evidence from a 30-year longitudinal study. Br J Psychiatry 2008; 193(6): 444–51.
100
49. Biaggi A, Conroy S, Pawlby S, Pariante CM. Identifying the women at risk of antenatal anxiety and depression: A systematic review. J Affect Disord 2016; 191: 62–77.
101
50. Wellings K, Jones KG, Mercer CH, et al. The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet 2013; 382(9907): 1807–16.
102
51. Nappi RE, Lobo Abascal P, Mansour D, Rabe T, Shojai R, Emergency Contraception Study G. Use of and attitudes towards emergency contraception: a survey of women in five European countries. Eur J Contracept Reprod Health Care 2014; 19(2): 93–101.
103
19. National Health Service. Sexual and Reproductive Health Services – England 2016–17. https://digital.nhs.uk/catalogue/PUB30094.
104
51. Nappi RE, Lobo Abascal P, Mansour D, Rabe T, Shojai R, Emergency Contraception Study G. Use of and attitudes towards emergency contraception: a survey of women in five European countries. Eur J Contracept Reprod Health Care 2014; 19(2): 93–101.
105
52. Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta-analysis. Lancet 2010; 375(9714): 555–62.
106
53. Marston C, Meltzer H, Majeed A. Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys. BMJ 2005; 331(7511): 271.
107
19. National Health Service. Sexual and Reproductive Health Services – England 2016–17. https://digital.nhs.uk/catalogue/PUB30094.
108
54. Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012; 27(7): 1994–2000.
109
55. Department of Health and Social Care. Report on abortion statistics in England and Wales for 2016. 2017. https://www.gov.uk/government/statistics/report-on-abortion-statistics-in-england-and-wales-for-2016.
110
В России для проведения этой процедуры можно обратиться как в районную поликлинику (где, вероятно, дадут направление в специализированное учреждение), так и в женскую консультацию и частную клинику. Выбор остается за женщиной. – Прим. изд.
111
55. Department of Health and Social Care. Report on abortion statistics in England and Wales for 2016. 2017. https://www.gov.uk/government/statistics/report-on-abortion-statistics-in-england-and-wales-for-2016.
112
56. Livshits A, Machtinger R, David LB, Spira M, Moshe-Zahav A, Seidman DS. Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study. Fertil Steril 2009; 91(5): 1877–80.
113
Британские клиники сексуального здоровья (sexual health clinics) занимаются обследованием населения на ИППП и ВИЧ, вакцинацией от гепатита В, профилактикой, там можно бесплатно получить презервативы, сделать тест на беременность, получить направление к специалисту, на консультацию. Если женщина задумывается о прерывании беременности, предоставляется психологическая и иная помощь, в том числе жертвам сексуального насилия, поэтому считать такие клиники полными аналогами российских кожно-венерологических диспансеров нельзя. В государственных клиниках сексуального здоровья все услуги бесплатные. – Прим. перев.
114
57. Halpern V, Raymond EG, Lopez LM. Repeated use of pre– and postcoital hormonal contraception for prevention of pregnancy. Cochrane Database Syst Rev 2014; (9): CD007595.
115
51. Nappi RE, Lobo Abascal P, Mansour D, Rabe T, Shojai R, Emergency Contraception Study G. Use of and attitudes towards emergency contraception: a survey of women in five European countries. Eur J Contracept Reprod Health Care 2014; 19(2): 93–101.
116
58. Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss. Hum Reprod Update 2002; 8(4): 333–43.
117
59. Lohr PA, Fjerstad M, DeSilva U, Lyus R. Abortion: Clinical Review. British Medical Journal 2015; 348: f7553.
118
55.?Department of Health and Social Care. Report on abortion statistics in England and Wales for 2016. 2017. https://www.gov.uk/government/statistics/report-on-abortion-statistics-in-england-and-wales-for-2016.
119
60. Wilson E, Free C, Morris TP, et al. Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial. PLoS Med 2017; 14(12): e1002479.
120
61. Sonnenberg P, Ison CA, Clifton S, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol 2015; 44(6): 1982–94.
121
62. Wiesenfeld HC, Manhart LE. Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen. J Infect Dis 2017; 216(suppl_2): S389–S95.
122
63. Kingston M, French P, Higgins S, et al. UK national guidelines on the management of syphilis 2015. Int J STD AIDS 2016; 27(6): 421–46.
123
64. Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med 2015; 372(21): 2039–48.
124
65. Korostil IA, Ali H, Guy RJ, Donovan B, Law MG, Regan DG. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males. Sex Transm Dis 2013; 40(11): 833–5.
125
66. Garland SM, Steben M. Genital herpes. Best Pract Res Clin Obstet Gynaecol 2014; 28(7): 1098–110.
126
67. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 2008; 168(11): 1137–44.
127
68. Public Health England. Towards elimination of HIV transmission, AIDS and HIV-related deaths in the UK 2017. https://assets.publishing.service.gov.uk/government/uploads/ system/uploads/attachment_data/file/675809/ Towards_elimination_of_HIV_ transmission_AIDS_and_HIV_related_deaths_in_the_UK.pdf.
128
69. Antiretroviral Therapy Cohort C. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 2017; 4(8): e349-e56.
129
70. Rodger AJ, Cambiano V, Bruun T, et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA 2016; 316(2): 171–81.
130
71. Ballini A, Cantore S, Fatone L, et al. Transmission of nonviral sexually transmitted infections and oral sex. J Sex Med 2012; 9(2): 372–84.
131
72. Chow EPF, Walker S, Hocking JS, et al. A multicentre doubleblind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol. BMC Infect Dis 2017; 17(1): 456.
132
73. Chow EP, Howden BP, Walker S, et al. Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomized controlled trial and an in vitro study. Sex Transm Infect 2017; 93(2): 88–93.
133
22. Cancer Research UK. Cancer mortality statistics. 2017. http://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality/common-cancers-compared.
134
74. Giannaki M, Kakourou T, Theodoridou M, et al. Human papillomavirus (HPV) genotyping of cutaneous warts in Greek children. Pediatr Dermatol 2013; 30(6): 730–5.
135
75. Davies S. The cervical smear test: does timing have an effect on sample adequacy? Cytopathology 2006; 17(4): 182–6.
136
79. Mouchet J, Salvo F, Raschi E, et al. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. Pharmacol Res 2018.
137
77. Kyrgiou M, Mitra A, Arbyn M, et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 2014; 349: g6192.
138
78. Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372(8): 711–23.
139
79. Mouchet J, Salvo F, Raschi E, et al. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. Pharmacol Res 2018.
140
80. Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. Assessment report. Review under Article 20 of Regulation (EC) № 726/2004, human papillomavirus (HPV) vaccines. EMA/762033/2015., 2015.
141
81. Drolet M, Benard E, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15(5): 565–80.
142
83. Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 2013; 130(2):264–8.
143
83. Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 2013; 130(2):264–8.
144
84. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005; 117(4): 629–37.
145
1. Barnhart KT, Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertil Steril 2009; 91(3): 659–63.
146
2. Glasier A. Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 2002; 65(1): 29–37.
147
3. Stoddard AM, Xu H, Madden T, Allsworth JE, Peipert JF. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care 2015; 20(3): 223–30.
148
4. Jain J, Dutton C, Nicosia A, Wajszczuk C, Bode FR, Mishell DR, Jr. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception 2004; 70(1): 11–8.
149
5. Steiner AZ, Pritchard D, Stanczyk FZ, et al. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA 2017; 318(14): 1367–76.
150
6. Birch Petersen K, Hvidman HW, Forman JL, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod 2015; 30(10): 2364–75.
151
7. Qi X, Pang Y, Qiao J. The role of anti-Mullerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2016; 199: 82–7.
152
8. Colombo B, Masarotto G. Daily fecundability: first results from a new data base. Demogr Res 2000; 3: [39] p.
153
9. Manders M, McLindon L, Schulze B, Beckmann MM, Kremer JA, Farquhar C. Timed intercourse for couples trying to conceive. Cochrane Database Syst Rev 2015; (3): CD011345.
154
10. Levine H, Jorgensen N, Martino-Andrade A, et al. Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update 2017; 23(6): 646–59.
155
11. Kovac JR, Khanna A, Lipshultz LI. The effects of cigarette smoking on male fertility. Postgrad Med 2015; 127(3): 338–41.
156
12. Ricci E, Al Beitawi S, Cipriani S, et al. Semen quality and alcohol intake: a systematic review and meta-analysis. Reprod Biomed Online 2017; 34(1): 38–47.
157
14. Grieger JA, Grzeskowiak LE, Bianco-Miotto T, et al. Pre-pregnancy fast food and fruit intake is associated with time to pregnancy. Hum Reprod 2018; 33(6): 1063–70.
158
15. Karayiannis D, Kontogianni MD, Mendorou C, Douka L, Mastrominas M, Yiannakouris N. Association between adherence to the Mediterranean diet and semen quality parameters in male partners of couples attempting fertility. Hum Reprod 2017; 32(1): 215–22.
159
16. Muscogiuri G, Palomba S, Lagana AS, Orio F. Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. Curr Pharm Des 2016; 22(36): 5554–7.
160
17. Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Antioxidants for female subfertility. Cochrane Database Syst Rev 2017; 7: CD007807.
161
18. Obeid R, Holzgreve W, Pietrzik K. Is 5-methyltetrahydrofolate analternative to folic acid for the prevention of neural tube defects? J Perinat Med 2013; 41(5): 469–83.
162
19. Gaskins AJ, Chavarro JE. Diet and fertility: a review. Am J Obstet Gynecol 2018; 218(4): 379–89.
163
19. Gaskins AJ, Chavarro JE. Diet and fertility: a review. Am J Obstet Gynecol 2018; 218(4): 379–89.
164
20. Garcia-Larsen V, Ierodiakonou D, Jarrold K, et al. Diet during pregnancy and infancy and risk of allergic or autoimmune disease: A systematic review and meta-analysis. PLoS Med 2018; 15(2): e1002507.
165
21. Van Heertum K, Rossi B. Alcohol and fertility: how much is too much? Fertil Res Pract 2017; 3: 10.
166
22. Lyngso J, Ramlau-Hansen CH, Bay B, Ingerslev HJ, Hulman A, Kesmodel US. Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose-response meta-analysis. Clin Epidemiol 2017; 9: 699–719.
167
23. Owe KM, Nystad W, Stigum H, Vangen S, Bo K. Exercise during pregnancy and risk of cesarean delivery in nulliparous women: a large population-based cohort study. Am J Obstet Gynecol 2016; 215(6): 791 e1– e13.
168
24. King R, Dempsey M, Valentine KA. Measuring sperm backflow following female orgasm: a new method. Socioaffect Neurosci Psychol 2016; 6: 31927.
169
25. Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand 2017; 96(6): 659–67.
170
26. Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2014; (3): CD009590.
171
27. Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 2014; (4): CD011031.
172
28. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188(1): 100–7.
173
29. Cobo A, Garcia-Velasco JA, Coello A, Domingo J, Pellicer A, Remohi J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016; 105(3): 755–64 e8.
174
В России процедура криоконсервации регулируется приказом № 107н «О порядке использования вспомогательных репродуктивных технологий». – Прим. изд.
175
30. Mesen TB, Mersereau JE, Kane JB, Steiner AZ. Optimal timing for elective egg freezing. Fertil Steril 2015; 103(6): 1551-6 e1-4.
176
1. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer 2018; 118(8): 1130–41.
177
1. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer 2018; 118(8): 1130–41.
178
2. Joseph DN, Whirledge S. Stress and the HPA Axis: Balancing Homeostasis and Fertility. Int J Mol Sci 2017; 18(10).
179
3. Vanman EJ, Baker R, Tobin SJ. The burden of online friends: the effects of giving up Facebook on stress and well-being. J Soc Psychol 2018; 158(4): 496–507.
180
4. Fenster L, Waller K, Chen J, et al. Psychological stress in the workplace and menstrual function. Am J Epidemiol 1999; 149(2): 127–34.
181
5. Torner L. Actions of Prolactin in the Brain: From Physiological Adaptations to Stress and Neurogenesis to Psychopathology. Front Endocrinol (Lausanne) 2016; 7: 25.
182
6. Wang L, Wang X, Wang W, et al. Stress and dysmenorrhoea: a population based prospective study. Occup Environ Med 2004; 61(12): 1021–6.
183
7. Chen YT, Tenforde AS, Fredericson M. Update on stress fractures in female athletes: epidemiology, treatment, and prevention. Curr Rev Musculoskelet Med 2013; 6(2): 173–81.
184
8. Jimena P, Castilla JA, Peran F, et al. Adrenal hormones in human follicular fluid. Acta Endocrinol (Copenh) 1992; 127(5): 403–6.
185
9. Nargund VH. Effects of psychological stress on male fertility. Nat Rev Urol 2015; 12(7): 373–82.
186
10. Frederiksen Y, Farver-Vestergaard I, Skovgard NG, Ingerslev HJ, Zachariae R. Efficacy of psychosocial interventions for psychological and pregnancy outcomes in infertile women and men: a systematic review and meta-analysis. BMJ Open 2015; 5(1): e006592.
187
11. Akimoto-Gunther L, Bonfim-Mendonca Pde S, Takahachi G, et al. Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity. PLoS One 2016; 11(7): e0158870.
188
12. Nansel TR, Riggs MA, Yu KF, Andrews WW, Schwebke JR, Klebanoff MA. The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort. Am J Obstet Gynecol 2006; 194(2): 381–6.
189
13. Cutter WJ, Norbury R, Murphy DG. Oestrogen, brain function, and neuropsychiatric disorders. J Neurol Neurosurg Psychiatry 2003; 74(7): 837–40.
190
14. Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev 2011; 31(7): 1183–91.
191
15. Tiggemann M, Hayden S, Brown Z, Veldhuis J. The effect of Instagram “likes” on women’s social comparison and body dissatisfaction. Body Image 2018; 26: 90–7.
192
3. Vanman EJ, Baker R, Tobin SJ. The burden of online friends: the effects of giving up Facebook on stress and well-being. J Soc Psychol 2018; 158(4): 496–507.
193
16. Gorczyca AM, Sjaarda LA, Mitchell EM, et al. Changes in macronutrient, micronutrient, and food group intakes throughout the menstrual cycle in healthy, premenopausal women. Eur J Nutr 2016; 55(3): 1181–8.
194
17. Hildebrandt BA, Racine SE, Keel PK, et al. The effects of ovarian hormones and emotional eating on changes in weight preoccupation across the menstrual cycle. Int J Eat Disord 2015; 48(5): 477–86.
195
18. Aune D, Giovannucci E, Boffetta P, et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol 2017; 46(3):1029–56.
196
19. Tavallaee M, Joffres MR, Corber SJ, Bayanzadeh M, Rad MM. The prevalence of menstrual pain and associated risk factors among Iranian women. J Obstet Gynaecol Res 2011; 37(5): 442–51.
197
20. Parazzini F, Di Martino M, Candiani M, Vigano P. Dietary components and uterine leiomyomas: a review of published data. Nutr Cancer 2015; 67(4): 569–79.
198
21. Harris HR, Eke AC, Chavarro JE, Missmer SA. Fruit and vegetable consumption and risk of endometriosis. Hum Reprod 2018; 33(4): 715–27.
199
22. NHS Digital HaSCIC. Health Survey for England 2016; Fruit & Vegetables. 2016. http://healthsurvey.hscic.gov.uk/datavisualisation/data-visualisation/explore-the-trends/fruitvegetables.aspx.
200
23. Zhao J, Lyu C, Gao J, et al. Dietary fat intake and endometrial cancer risk: A dose response meta-analysis. Medicine (Baltimore) 2016; 95(27): e4121.
201
24. Qiu W, Lu H, Qi Y, Wang X. Dietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Oncotarget 2016; 7(24): 37390–406.
202
25. Thorning TK, Raben A, Tholstrup T, Soedamah-Muthu SS, Givens I, Astrup A. Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence. Food Nutr Res 2016; 60: 32527.
203
26. Chavarro JE, Rich-Edwards JW, Rosner B, Willett WC. A prospective study of dairy foods intake and anovulatory infertility. Hum Reprod 2007; 22(5): 1340–7.
204
27. LaRosa CL, Quach KA, Koons K, et al. Consumption of dairy in teenagers with and without acne. J Am Acad Dermatol 2016; 75(2): 318–22.
205
28. Food Standards Agency and Public Health England. National Diet and Nutrition Survey (NDNS) 2018.
206
29. Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: Physiological and clinical implications.Maturitas 2017; 103: 45–53.
207
30. Mueller NT, Duncan BB, Barreto SM, et al. Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Cardiovasc Diabetol 2014; 13: 22.
208
31. Gong TT, Wu QJ, Vogtmann E, Lin B, Wang YL. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int J Cancer 2013; 132(12): 2894–900.
209
32. Collaborative Group on Hormonal Factors in Breast C. Menarche, menopause, and breast cancer risk: individual participant metaanalysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012; 13(11): 1141–51.
210
33. Mueller NT, Jacobs DR, Jr., MacLehose RF, et al. Consumption of caffeinated and artificially sweetened soft drinks is associated with risk of early menarche. Am J Clin Nutr 2015; 102(3): 648–54.
211
34. Cheng G, Buyken AE, Shi L, et al. Beyond overweight: nutrition as an important lifestyle factor influencing timing of puberty. Nutr Rev 2012; 70(3): 133–52.
212
35. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011; 57(11): 1299–313.
213
36. Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a lowcarbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008; 359(3): 229–41.
214
37. Rogerson D. Vegan diets: practical advice for athletes and exercisers. J Int Soc Sports Nutr 2017; 14: 36.
215
38. Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol 2013; 177(5): 420–30.
216
38. Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol 2013; 177(5): 420–30.
217
39. Myung SK, Ju W, Choi HJ, Kim SC, Korean Meta-Analysis Study G. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG 2009; 116(13): 1697–705.
218
40. Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2011; 125(2): 315–23.
219
41. Jamilian M, Asemi Z. The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2016; 101(9): 3386–94.
220
42. Thoma ME, Klebanoff MA, Rovner AJ, et al. Bacterial vaginosis is associated with variation in dietary indices. J Nutr 2011; 141(9): 1698–704.
221
43. Marco ML, Heeney D, Binda S, et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 2017; 44: 94–102.
222
44. Public Health England. Health matters: getting every adult active every day. 2016.
223
45. Matthewman G, Lee A, Kaur JG, Daley AJ. Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2018.
224
46. Thomas RJ, Kenfield SA, Jimenez A. Exercise-induced biochemical changes and their potential influence on cancer: a scientific review. Br J Sports Med 2017; 51(8): 640–4.
225
47. Boutcher SH. High-intensity intermittent exercise and fat loss. J Obes 2011; 2011: 868305.
226
49. Carvalhais A, Natal Jorge R, Bo K. Performing high-level sport is strongly associated with urinary incontinence in elite athletes: a comparative study of 372 elite female athletes and 372 controls. Br J Sports Med 2017.
227
50. Teixeira RV, Colla C, Sbruzzi G, Mallmann A, Paiva LL. Prevalence of urinary incontinence in female athletes: a systematic review with meta-analysis. Int Urogynecol J 2018.
228
51. Woodyard C. Exploring the therapeutic effects of yoga and its ability to increase quality of life. Int J Yoga 2011; 4(2): 49–54.
229
52. Oates J. The Effect of Yoga on Menstrual Disorders: A Systematic Review. J Altern Complement Med 2017; 23(6): 407–17.
230
53. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Effects of a holistic yoga program on endocrine parameters in adolescents with polycystic ovarian syndrome: a randomized controlled trial. J Altern Complement Med 2013; 19(2): 153–60.
231
54. Oosthuyse T, Bosch AN. The effect of the menstrual cycle on exercise metabolism: implications for exercise performance in eumenorrhoeic women. Sports Med 2010; 40(3): 207–27.
232
45. Matthewman G, Lee A, Kaur JG, Daley AJ. Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2018.
233
7. Chen YT, Tenforde AS, Fredericson M. Update on stress fractures in female athletes: epidemiology, treatment, and prevention. Curr Rev Musculoskelet Med 2013; 6(2): 173–81.
234
55. Sleep Council. The Great British Bedtime Report 2017. 2018. https://sleepcouncil.org.uk/sdm_downloads/ the-great-british-bedtime-report-2017/.
235
55. Sleep Council. The Great British Bedtime Report 2017. 2018. https://sleepcouncil.org.uk/sdm_downloads/ the-great-british-bedtime-report-2017/.
236
56. Donga E, van Dijk M, van Dijk JG, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab 2010; 95(6): 2963–8.
237
57. Romans SE, Kreindler D, Einstein G, Laredo S, Petrovic MJ, Stanley J. Sleep quality and the menstrual cycle. Sleep Med 2015; 16(4): 489–95.
238
58. Webley GE, Leidenberger F. The circadian pattern of melatonin and its positive relationship with progesterone in women. J Clin Endocrinol Metab 1986; 63(2): 323–8.
239
59. Jehan S, Auguste E, Hussain M, et al. Sleep and Premenstrual Syndrome. J Sleep Med Disord 2016; 3(5).
240
60. Baker FC, Mitchell D, Driver HS. Oral contraceptives alter sleep and raise body temperature in young women. Pflugers Arch 2001; 442(5): 729–37.
241
61. Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 2017; 359: j5024.
242
62. Fenster L, Quale C, Waller K, et al. Caffeine consumption and menstrual function. Am J Epidemiol 1999; 149(6): 550–7.
243
63. Whelan EA, Sandler DP, McConnaughey DR, Weinberg CR. Menstrual and reproductive characteristics and age at natural menopause. Am J Epidemiol 1990; 131(4): 625–32.
244
55. Sleep Council. The Great British Bedtime Report 2017. 2018. https://sleepcouncil.org.uk/sdm_downloads/ the-great-british-bedtime-report-2017/.
245
64. Evans SM, Levin FR. Response to alcohol in women: role of the menstrual cycle and a family history of alcoholism. Drug Alcohol Depend 2011; 114(1): 18–30.
246
65. van der Schuur WA, Baumgartner SE, Sumter SR. Social Media Use, Social Media Stress, and Sleep: Examining Cross-Sectional and Longitudinal Relationships in Adolescents. Health Commun 2018: 1–8.
247
66. Li C, Kee YH, Lam LS. Effect of Brief Mindfulness Induction on University Athletes’ Sleep Quality Following Night Training. Front Psychol 2018; 9: 508.
248
67. Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: Are Some Patients Taking the Quantified Self Too Far? J Clin Sleep Med 2017; 13(2): 351–4.
 Вернуться к просмотру книги
|
Читать книгу « Женское здоровье. Без стыда и глупостей »
© 2020 LoveRead.ec - электронная библиотека в которой можно
читать онлайн книги бесплатно
.
Все материалы взяты из открытых источников и представлены исключительно в ознакомительных целях.
Все права на книгу Женское здоровье. Без стыда и глупостей
принадлежат автору Анита Митра и издательствам.